Karyopharm to present selinexor data at the 66th american society of hematology annual meeting and exposition

Newton, mass. , nov. 18, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced abstracts detailing selinexor data have been selected to be presented at the 66th american society of hematology (ash) annual meeting and exposition, being held december 7-10, 2024 in san diego, ca.
KPTI Ratings Summary
KPTI Quant Ranking